Combination therapy strengthens T cells in melanoma pre-clinical study

A pre-clinical study of two drugs designed to boost T cell performance, has revealed the agents, when give in combination, may enhance the immune system’s ability to kill melanoma tumors deficient in the tumor suppressor gene PTEN. The study was led by investigators at The University of Texas MD Anderson Cancer Center.

Go to Source

(Visited 5 times, 1 visits today)

Site Footer

Sliding Sidebar